Loading...
Header Logo
Keywords
Last Name
Institution

RALF KRAHE

TitleProfessor
InstitutionMD Anderson
DepartmentGenetics
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Corrales E, Vásquez M, Zhang B, Santamaría-Ulloa C, Cuenca P, Krahe R, Monckton DG, Morales F. Analysis of mutational dynamics at the DMPK (CTG)n locus identifies saliva as a suitable DNA sample source for genetic analysis in myotonic dystrophy type 1. PLoS One. 2019; 14(5):e0216407. PMID: 31048891.
      View in: PubMed
    2. Larsson CA, Moyer SM, Liu B, Michel KA, Pant V, Yang P, Wong J, El-Naggar AK, Krahe R, Lozano G. Synergistic and additive effect of retinoic acid in circumventing resistance to p53 restoration. Proc Natl Acad Sci U S A. 2018 02 27; 115(9):2198-2203. PMID: 29440484.
      View in: PubMed
    3. Qian DC, Molfese DL, Jin JL, Titus AJ, He Y, Li Y, Vaissié M, Viswanath H, Baldwin PR, Krahe R, Salas R, Amos CI. Genome-wide imaging association study implicates functional activity and glial homeostasis of the caudate in smoking addiction. BMC Genomics. 2017 Sep 19; 18(1):740. PMID: 28927378.
      View in: PubMed
    4. Yenigun VB, Sirito M, Amcheslavky A, Czernuszewicz T, Colonques-Bellmunt J, García-Alcover I, Wojciechowska M, Bolduc C, Chen Z, López Castel A, Krahe R, Bergmann A. (CCUG)n RNA toxicity in a Drosophila model of myotonic dystrophy type 2 (DM2) activates apoptosis. Dis Model Mech. 2017 08 01; 10(8):993-1003. PMID: 28623239.
      View in: PubMed
    5. Chakraborty S, Vatta M, Bachinski LL, Krahe R, Dlouhy S, Bai S. Molecular Diagnosis of Myotonic Dystrophy. Curr Protoc Hum Genet. 2016 10 11; 91:9.29.1-9.29.19. PMID: 27727437.
      View in: PubMed
    6. Chen Q, Sinha K, Deng JM, Yasuda H, Krahe R, Behringer RR, de Crombrugghe B. Mesenchymal Deletion of Histone Demethylase NO66 in Mice Promotes Bone Formation. J Bone Miner Res. 2015 Sep; 30(9):1608-17. PMID: 25736226.
      View in: PubMed
    7. Chen Q, Zhang L, de Crombrugghe B, Krahe R. Mesenchyme-specific overexpression of nucleolar protein 66 in mice inhibits skeletal growth and bone formation. FASEB J. 2015 Jun; 29(6):2555-65. PMID: 25746793.
      View in: PubMed
    8. Screen M, Jonson PH, Raheem O, Palmio J, Laaksonen R, Lehtimäki T, Sirito M, Krahe R, Hackman P, Udd B. Abnormal splicing of NEDD4 in myotonic dystrophy type 2: possible link to statin adverse reactions. Am J Pathol. 2014 Aug; 184(8):2322-32. PMID: 24907641.
      View in: PubMed
    9. Bachinski LL, Baggerly KA, Neubauer VL, Nixon TJ, Raheem O, Sirito M, Unruh AK, Zhang J, Nagarajan L, Timchenko LT, Bassez G, Eymard B, Gamez J, Ashizawa T, Mendell JR, Udd B, Krahe R. Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies. Neuromuscul Disord. 2014 Mar; 24(3):227-40. PMID: 24332166.
      View in: PubMed
    10. Vihola A, Sirito M, Bachinski LL, Raheem O, Screen M, Suominen T, Krahe R, Udd B. Altered expression and splicing of Ca(2+) metabolism genes in myotonic dystrophies DM1 and DM2. Neuropathol Appl Neurobiol. 2013 Jun; 39(4):390-405. PMID: 22758909.
      View in: PubMed
    11. Udd B, Krahe R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol. 2012 Oct; 11(10):891-905. PMID: 22995693.
      View in: PubMed
    12. Izaguirre DI, Zhu W, Hai T, Cheung HC, Krahe R, Cote GJ. PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis. Mol Carcinog. 2012 Nov; 51(11):895-906. PMID: 21976412.
      View in: PubMed
    13. Fang S, Krahe R, Bachinski LL, Zhang B, Amos CI, Strong LC. Sex-specific effect of the TP53 PIN3 polymorphism on cancer risk in a cohort study of TP53 germline mutation carriers. Hum Genet. 2011 Dec; 130(6):789-94. PMID: 21688173.
      View in: PubMed
    14. Udd B, Meola G, Krahe R, Wansink DG, Bassez G, Kress W, Schoser B, Moxley R. Myotonic dystrophy type 2 (DM2) and related disorders report of the 180th ENMC workshop including guidelines on diagnostics and management 3-5 December 2010, Naarden, The Netherlands. Neuromuscul Disord. 2011 Jun; 21(6):443-50. PMID: 21543227.
      View in: PubMed
    15. Suominen T, Bachinski LL, Auvinen S, Hackman P, Baggerly KA, Angelini C, Peltonen L, Krahe R, Udd B. Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland. Eur J Hum Genet. 2011 Jul; 19(7):776-82. PMID: 21364698.
      View in: PubMed
    16. Wu CC, Krahe R, Lozano G, Zhang B, Wilson CD, Jo EJ, Amos CI, Shete S, Strong LC. Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome. Hum Genet. 2011 Jun; 129(6):663-73. PMID: 21305319.
      View in: PubMed
    17. Bachinski LL, Sirito M, Böhme M, Baggerly KA, Udd B, Krahe R. Altered MEF2 isoforms in myotonic dystrophy and other neuromuscular disorders. Muscle Nerve. 2010 Dec; 42(6):856-63. PMID: 21104860.
      View in: PubMed
    18. Raheem O, Olufemi SE, Bachinski LL, Vihola A, Sirito M, Holmlund-Hampf J, Haapasalo H, Li YP, Udd B, Krahe R. Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2. Am J Pathol. 2010 Dec; 177(6):3025-36. PMID: 20971734.
      View in: PubMed
    19. Richards KL, Zhang B, Sun M, Dong W, Churchill J, Bachinski LL, Wilson CD, Baggerly KA, Yin G, Hayes DN, Wistuba II, Krahe R. Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancers. Cancer. 2011 Feb 01; 117(3):606-17. PMID: 20945327.
      View in: PubMed
    20. Fang S, Krahe R, Lozano G, Han Y, Chen W, Post SM, Zhang B, Wilson CD, Bachinski LL, Strong LC, Amos CI. Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations. PLoS One. 2010 May 26; 5(5):e10813. PMID: 20520810.
      View in: PubMed
    21. Sammons MA, Antons AK, Bendjennat M, Udd B, Krahe R, Link AJ. ZNF9 activation of IRES-mediated translation of the human ODC mRNA is decreased in myotonic dystrophy type 2. PLoS One. 2010 Feb 18; 5(2):e9301. PMID: 20174632.
      View in: PubMed
    22. Vihola A, Bachinski LL, Sirito M, Olufemi SE, Hajibashi S, Baggerly KA, Raheem O, Haapasalo H, Suominen T, Holmlund-Hampf J, Paetau A, Cardani R, Meola G, Kalimo H, Edström L, Krahe R, Udd B. Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2. Acta Neuropathol. 2010 Apr; 119(4):465-79. PMID: 20066428.
      View in: PubMed
    23. Hu J, He X, Cote GJ, Krahe R. Singular Value Decomposition-based Alternative Splicing Detection. J Am Stat Assoc. 2009 Sep 01; 104(487):944-953. PMID: 20305737.
      View in: PubMed
    24. Salisbury E, Schoser B, Schneider-Gold C, Wang GL, Huichalaf C, Jin B, Sirito M, Sarkar P, Krahe R, Timchenko NA, Timchenko LT. Expression of RNA CCUG repeats dysregulates translation and degradation of proteins in myotonic dystrophy 2 patients. Am J Pathol. 2009 Aug; 175(2):748-62. PMID: 19590039.
      View in: PubMed
    25. Cheung HC, Hai T, Zhu W, Baggerly KA, Tsavachidis S, Krahe R, Cote GJ. Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines. Brain. 2009 Aug; 132(Pt 8):2277-88. PMID: 19506066.
      View in: PubMed
    26. Lott ST, Chen N, Chandler DS, Yang Q, Wang L, Rodriguez M, Xie H, Balasenthil S, Buchholz TA, Sahin AA, Chaung K, Zhang B, Olufemi SE, Chen J, Adams H, Band V, El-Naggar AK, Frazier ML, Keyomarsi K, Hunt KK, Sen S, Haffty B, Hewitt SM, Krahe R, Killary AM. DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer. PLoS Med. 2009 May 26; 6(5):e1000068. PMID: 19536326.
      View in: PubMed
    27. Richards KL, Zhang B, Baggerly KA, Colella S, Lang JC, Schuller DE, Krahe R. Genome-wide hypomethylation in head and neck cancer is more pronounced in HPV-negative tumors and is associated with genomic instability. PLoS One. 2009; 4(3):e4941. PMID: 19293934.
      View in: PubMed
    28. Wang Y, Carlton VE, Karlin-Neumann G, Sapolsky R, Zhang L, Moorhead M, Wang ZC, Richardson AL, Warren R, Walther A, Bondy M, Sahin A, Krahe R, Tuna M, Thompson PA, Spellman PT, Gray JW, Mills GB, Faham M. High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarrays. BMC Med Genomics. 2009 Feb 19; 2:8. PMID: 19228381.
      View in: PubMed
    29. Edwards SF, Sirito M, Krahe R, Sinden RR. A Z-DNA sequence reduces slipped-strand structure formation in the myotonic dystrophy type 2 (CCTG) x (CAGG) repeat. Proc Natl Acad Sci U S A. 2009 Mar 03; 106(9):3270-5. PMID: 19218442.
      View in: PubMed
    30. Bachinski LL, Czernuszewicz T, Ramagli LS, Suominen T, Shriver MD, Udd B, Siciliano MJ, Krahe R. Premutation allele pool in myotonic dystrophy type 2. Neurology. 2009 Feb 10; 72(6):490-7. PMID: 19020295.
      View in: PubMed
    31. Auvinen S, Suominen T, Hannonen P, Bachinski LL, Krahe R, Udd B. Myotonic dystrophy type 2 found in two of sixty-three persons diagnosed as having fibromyalgia. Arthritis Rheum. 2008 Nov; 58(11):3627-31. PMID: 18975316.
      View in: PubMed
    32. Colella S, Richards KL, Bachinski LL, Baggerly KA, Tsavachidis S, Lang JC, Schuller DE, Krahe R. Molecular signatures of metastasis in head and neck cancer. Head Neck. 2008 Oct; 30(10):1273-83. PMID: 18642293.
      View in: PubMed
    33. Suominen T, Schoser B, Raheem O, Auvinen S, Walter M, Krahe R, Lochmüller H, Kress W, Udd B. High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany. J Neurol. 2008 Nov; 255(11):1731-6. PMID: 18807109.
      View in: PubMed
    34. Cheung HC, Baggerly KA, Tsavachidis S, Bachinski LL, Neubauer VL, Nixon TJ, Aldape KD, Cote GJ, Krahe R. Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays. BMC Genomics. 2008 May 12; 9:216. PMID: 18474104.
      View in: PubMed
    35. Müller JS, Herczegfalvi A, Vilchez JJ, Colomer J, Bachinski LL, Mihaylova V, Santos M, Schara U, Deschauer M, Shevell M, Poulin C, Dias A, Soudo A, Hietala M, Aärimaa T, Krahe R, Karcagi V, Huebner A, Beeson D, Abicht A, Lochmüller H. Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes. Brain. 2007 Jun; 130(Pt 6):1497-506. PMID: 17439981.
      View in: PubMed
    36. Simeone AM, Nieves-Alicea R, McMurtry VC, Colella S, Krahe R, Tari AM. Cyclooxygenase-2 uses the protein kinase C/ interleukin-8/urokinase-type plasminogen activator pathway to increase the invasiveness of breast cancer cells. Int J Oncol. 2007 Apr; 30(4):785-92. PMID: 17332916.
      View in: PubMed
    37. Udd B, Meola G, Krahe R, Thornton C, Ranum LP, Bassez G, Kress W, Schoser B, Moxley R. 140th ENMC International Workshop: Myotonic Dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management. Neuromuscul Disord. 2006 Jun; 16(6):403-13. PMID: 16684600.
      View in: PubMed
    38. Maurage CA, Udd B, Ruchoux MM, Vermersch P, Kalimo H, Krahe R, Delacourte A, Sergeant N. Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease. Neurology. 2005 Nov 22; 65(10):1636-8. PMID: 16301494.
      View in: PubMed
    39. Simeone AM, Colella S, Krahe R, Johnson MM, Mora E, Tari AM. N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells. Carcinogenesis. 2006 Mar; 27(3):568-77. PMID: 16199439.
      View in: PubMed
    40. Ruteshouser EC, Hendrickson BW, Colella S, Krahe R, Pinto L, Huff V. Genome-wide loss of heterozygosity analysis of WT1-wild-type and WT1-mutant Wilms tumors. Genes Chromosomes Cancer. 2005 Jun; 43(2):172-80. PMID: 15761866.
      View in: PubMed
    41. Rotondo G, Sansone V, Cardani R, Mancinelli E, Krahe R, Stangalini D, Meola G. Proximal myotonic dystrophy mimicking progressive muscular atrophy. Eur J Neurol. 2005 Feb; 12(2):160-1. PMID: 15679706.
      View in: PubMed
    42. Bachinski LL, Olufemi SE, Zhou X, Wu CC, Yip L, Shete S, Lozano G, Amos CI, Strong LC, Krahe R. Genetic mapping of a third Li-Fraumeni syndrome predisposition locus to human chromosome 1q23. Cancer Res. 2005 Jan 15; 65(2):427-31. PMID: 15695383.
      View in: PubMed
    43. Van Goethem G, Luoma P, Rantamäki M, Al Memar A, Kaakkola S, Hackman P, Krahe R, Löfgren A, Martin JJ, De Jonghe P, Suomalainen A, Udd B, Van Broeckhoven C. POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology. 2004 Oct 12; 63(7):1251-7. PMID: 15477547.
      View in: PubMed
    44. Grewal RP, Zhang S, Ma W, Rosenberg M, Krahe R. Clinical and genetic analysis of a family with PROMM. J Clin Neurosci. 2004 Aug; 11(6):603-5. PMID: 15261229.
      View in: PubMed
    45. Sallinen R, Vihola A, Bachinski LL, Huoponen K, Haapasalo H, Hackman P, Zhang S, Sirito M, Kalimo H, Meola G, Horelli-Kuitunen N, Wessman M, Krahe R, Udd B. New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2). Neuromuscul Disord. 2004 Apr; 14(4):274-83. PMID: 15019706.
      View in: PubMed
    46. Tanner SM, Li Z, Bisson R, Acar C, Oner C, Oner R, Cetin M, Abdelaal MA, Ismail EA, Lissens W, Krahe R, Broch H, Gräsbeck R, de la Chapelle A. Genetically heterogeneous selective intestinal malabsorption of vitamin B12: founder effects, consanguinity, and high clinical awareness explain aggregations in Scandinavia and the Middle East. Hum Mutat. 2004 Apr; 23(4):327-33. PMID: 15024727.
      View in: PubMed
    47. Meola G, Sansone V, Perani D, Scarone S, Cappa S, Dragoni C, Cattaneo E, Cotelli M, Gobbo C, Fazio F, Siciliano G, Mancuso M, Vitelli E, Zhang S, Krahe R, Moxley RT. Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Neuromuscul Disord. 2003 Dec; 13(10):813-21. PMID: 14678804.
      View in: PubMed
    48. Miller BJ, Wang D, Krahe R, Wright FA. Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions. Am J Hum Genet. 2003 Oct; 73(4):748-67. PMID: 13680524.
      View in: PubMed
    49. Bachinski LL, Udd B, Meola G, Sansone V, Bassez G, Eymard B, Thornton CA, Moxley RT, Harper PS, Rogers MT, Jurkat-Rott K, Lehmann-Horn F, Wieser T, Gamez J, Navarro C, Bottani A, Kohler A, Shriver MD, Sallinen R, Wessman M, Zhang S, Wright FA, Krahe R. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect. Am J Hum Genet. 2003 Oct; 73(4):835-48. PMID: 12970845.
      View in: PubMed
    50. Udd B, Meola G, Krahe R, Thornton C, Ranum L, Day J, Bassez G, Ricker K. Report of the 115th ENMC workshop: DM2/PROMM and other myotonic dystrophies. 3rd Workshop, 14-16 February 2003, Naarden, The Netherlands. Neuromuscul Disord. 2003 Sep; 13(7-8):589-96. PMID: 12921797.
      View in: PubMed
    51. Colella S, Shen L, Baggerly KA, Issa JP, Krahe R. Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. Biotechniques. 2003 Jul; 35(1):146-50. PMID: 12866414.
      View in: PubMed
    52. Vihola A, Bassez G, Meola G, Zhang S, Haapasalo H, Paetau A, Mancinelli E, Rouche A, Hogrel JY, Laforêt P, Maisonobe T, Pellissier JF, Krahe R, Eymard B, Udd B. Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology. 2003 Jun 10; 60(11):1854-7. PMID: 12796551.
      View in: PubMed
    53. Auvinen S, Vihola A, Krahe R, Kupila J, Hackman P, Hietaharju A, Udd B. [A new type of myotonic dystrophy]. Duodecim. 2003; 119(8):707-13. PMID: 12806729.
      View in: PubMed
    54. Lemon WJ, Palatini JJ, Krahe R, Wright FA. Theoretical and experimental comparisons of gene expression indexes for oligonucleotide arrays. Bioinformatics. 2002 Nov; 18(11):1470-6. PMID: 12424118.
      View in: PubMed
    55. Miano JM, Kitchen CM, Chen J, Maltby KM, Kelly LA, Weiler H, Krahe R, Ashworth LK, Garcia E. Expression of human smooth muscle calponin in transgenic mice revealed with a bacterial artificial chromosome. Am J Physiol Heart Circ Physiol. 2002 May; 282(5):H1793-803. PMID: 11959645.
      View in: PubMed
    56. Zhang S, Krahe R. Physical and transcript map of a 2-Mb region in Xp22.1 containing candidate genes for X-linked mental retardation and short stature. Genomics. 2002 Mar; 79(3):274-7. PMID: 11863356.
      View in: PubMed
    57. Rantamäki M, Krahe R, Paetau A, Cormand B, Mononen I, Udd B. [New adult-onset ataxia in a Finnish family]. Duodecim. 2002; 118(20):2115-22. PMID: 12463002.
      View in: PubMed
    58. Karacay B, O'Dorisio MS, Kasow K, Hollenback C, Krahe R. Expression and fine mapping of murine vasoactive intestinal peptide receptor 1. J Mol Neurosci. 2001 Dec; 17(3):311-24. PMID: 11859927.
      View in: PubMed
    59. Barkardottir RB, Sarantaus L, Arason A, Vehmanen P, Bendahl PO, Kainu T, Syrjäkoski K, Krahe R, Huusko P, Pyrhönen S, Holli K, Kallioniemi OP, Egilsson V, Kere J, Nevanlinna H. Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families. Eur J Hum Genet. 2001 Oct; 9(10):773-9. PMID: 11781689.
      View in: PubMed
    60. Rantamäki M, Krahe R, Paetau A, Cormand B, Mononen I, Udd B. Adult-onset autosomal recessive ataxia with thalamic lesions in a Finnish family. Neurology. 2001 Sep 25; 57(6):1043-9. PMID: 11571332.
      View in: PubMed
    61. Wright FA, Lemon WJ, Zhao WD, Sears R, Zhuo D, Wang JP, Yang HY, Baer T, Stredney D, Spitzner J, Stutz A, Krahe R, Yuan B. A draft annotation and overview of the human genome. Genome Biol. 2001; 2(7):RESEARCH0025. PMID: 11516338.
      View in: PubMed
    62. Rush LJ, Dai Z, Smiraglia DJ, Gao X, Wright FA, Frühwald M, Costello JF, Held WA, Yu L, Krahe R, Kolitz JE, Bloomfield CD, Caligiuri MA, Plass C. Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci. Blood. 2001 May 15; 97(10):3226-33. PMID: 11342453.
      View in: PubMed
    63. Zhuo D, Zhao WD, Wright FA, Yang HY, Wang JP, Sears R, Baer T, Kwon DH, Gordon D, Gibbs S, Dai D, Yang Q, Spitzner J, Krahe R, Stredney D, Stutz A, Yuan B. Assembly, annotation, and integration of UNIGENE clusters into the human genome draft. Genome Res. 2001 May; 11(5):904-18. PMID: 11337484.
      View in: PubMed
    64. Pääkkönen K, Sauramo S, Sarantaus L, Vahteristo P, Hartikainen A, Vehmanen P, Ignatius J, Ollikainen V, Kääriäinen H, Vauramo E, Nevanlinna H, Krahe R, Holli K, Kere J. Involvement of BRCA1 and BRCA2 in breast cancer in a western Finnish sub-population. Genet Epidemiol. 2001 Feb; 20(2):239-46. PMID: 11180449.
      View in: PubMed
    65. Virtaneva K, Wright FA, Tanner SM, Yuan B, Lemon WJ, Caligiuri MA, Bloomfield CD, de La Chapelle A, Krahe R. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci U S A. 2001 Jan 30; 98(3):1124-9. PMID: 11158605.
      View in: PubMed
    66. Frühwald MC, O'Dorisio MS, Dai Z, Rush LJ, Krahe R, Smiraglia DJ, Pietsch T, Elsea SH, Plass C. Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs. Genes Chromosomes Cancer. 2001 Jan; 30(1):38-47. PMID: 11107174.
      View in: PubMed
    67. Sarantaus L, Huusko P, Eerola H, Launonen V, Vehmanen P, Rapakko K, Gillanders E, Syrjäkoski K, Kainu T, Vahteristo P, Krahe R, Pääkkönen K, Hartikainen J, Blomqvist C, Löppönen T, Holli K, Ryynänen M, Bützow R, Borg A, Wasteson Arver B, Holmberg E, Mannermaa A, Kere J, Kallioniemi OP, Winqvist R, Nevanlinna H. Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland. Eur J Hum Genet. 2000 Oct; 8(10):757-63. PMID: 11039575.
      View in: PubMed
    68. Wise DO, Krahe R, Oakley BR. The gamma-tubulin gene family in humans. Genomics. 2000 Jul 15; 67(2):164-70. PMID: 10903841.
      View in: PubMed
    69. Kristiansen M, Aminoff M, Jacobsen C, de La Chapelle A, Krahe R, Verroust PJ, Moestrup SK. Cubilin P1297L mutation associated with hereditary megaloblastic anemia 1 causes impaired recognition of intrinsic factor-vitamin B(12) by cubilin. Blood. 2000 Jul 15; 96(2):405-9. PMID: 10887099.
      View in: PubMed
    70. Kreiman G, Krahe R, Metzner W, Koch C, Gabbiani F. Robustness and variability of neuronal coding by amplitude-sensitive afferents in the weakly electric fish eigenmannia. J Neurophysiol. 2000 Jul; 84(1):189-204. PMID: 10899196.
      View in: PubMed
    71. Frühwald MC, O'Dorisio MS, Rush LJ, Reiter JL, Smiraglia DJ, Wenger G, Costello JF, White PS, Krahe R, Brodeur GM, Plass C. Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon. J Med Genet. 2000 Jul; 37(7):501-9. PMID: 10882752.
      View in: PubMed
    72. Pellegata NS, Dieguez-Lucena JL, Joensuu T, Lau S, Montgomery KT, Krahe R, Kivelä T, Kucherlapati R, Forsius H, de la Chapelle A. Mutations in KERA, encoding keratocan, cause cornea plana. Nat Genet. 2000 May; 25(1):91-5. PMID: 10802664.
      View in: PubMed
    73. New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). The International Myotonic Dystrophy Consortium (IDMC). Neurology. 2000 Mar 28; 54(6):1218-21. PMID: 10746587.
      View in: PubMed
    74. Kourlas PJ, Strout MP, Becknell B, Veronese ML, Croce CM, Theil KS, Krahe R, Ruutu T, Knuutila S, Bloomfield CD, Caligiuri MA. Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci U S A. 2000 Feb 29; 97(5):2145-50. PMID: 10681437.
      View in: PubMed
    75. Kozyraki R, Fyfe J, Kristiansen M, Gerdes C, Jacobsen C, Cui S, Christensen EI, Aminoff M, de la Chapelle A, Krahe R, Verroust PJ, Moestrup SK. The intrinsic factor-vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein. Nat Med. 1999 Jun; 5(6):656-61. PMID: 10371504.
      View in: PubMed
    76. Aminoff M, Carter JE, Chadwick RB, Johnson C, Gräsbeck R, Abdelaal MA, Broch H, Jenner LB, Verroust PJ, Moestrup SK, de la Chapelle A, Krahe R. Mutations in CUBN, encoding the intrinsic factor-vitamin B12 receptor, cubilin, cause hereditary megaloblastic anaemia 1. Nat Genet. 1999 Mar; 21(3):309-13. PMID: 10080186.
      View in: PubMed
    77. Miano JM, Garcia E, Krahe R. Radiation Hybrid (RH) Mapping of Human Smooth Muscle-Restricted Genes. Methods Mol Med. 1999; 30:25-35. PMID: 21341013.
      View in: PubMed
    78. Virtaneva K, Paulin L, Krahe R, de la Chapelle A, Lehesjoki AE. The minisatellite expansion mutation in EPM1: resolution of an initial discrepancy. Mutatations in brief no. 186. Online. Hum Mutat. 1998; 12(3):218. PMID: 10660338.
      View in: PubMed
    79. Miano JM, Krahe R, Garcia E, Elliott JM, Olson EN. Expression, genomic structure and high resolution mapping to 19p13.2 of the human smooth muscle cell calponin gene. Gene. 1997 Sep 15; 197(1-2):215-24. PMID: 9332369.
      View in: PubMed
    80. Udd B, Krahe R, Wallgren-Pettersson C, Falck B, Kalimo H. Proximal myotonic dystrophy--a family with autosomal dominant muscular dystrophy, cataracts, hearing loss and hypogonadism: heterogeneity of proximal myotonic syndromes? Neuromuscul Disord. 1997 Jun; 7(4):217-28. PMID: 9196902.
      View in: PubMed
    81. Virtaneva K, D'Amato E, Miao J, Koskiniemi M, Norio R, Avanzini G, Franceschetti S, Michelucci R, Tassinari CA, Omer S, Pennacchio LA, Myers RM, Dieguez-Lucena JL, Krahe R, de la Chapelle A, Lehesjoki AE. Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1. Nat Genet. 1997 Apr; 15(4):393-6. PMID: 9090386.
      View in: PubMed
    82. Bachinski LL, Abchee A, Durand JB, Roberts R, Krahe R, Hobson GM. Polymorphic trinucleotide repeat in the MEF2A gene at 15q26 is not expanded in familial cardiomyopathies. Mol Cell Probes. 1997 Feb; 11(1):55-8. PMID: 9076715.
      View in: PubMed
    83. Abbruzzese C, Krahe R, Liguori M, Tessarolo D, Siciliano MJ, Ashizawa T, Giacanelli M. Myotonic dystrophy phenotype without expansion of (CTG)n repeat: an entity distinct from proximal myotonic myopathy (PROMM)? J Neurol. 1996 Oct; 243(10):715-21. PMID: 8923304.
      View in: PubMed
    84. Iyer GS, Krahe R, Goodwin LA, Doggett NA, Siciliano MJ, Funanage VL, Proujansky R. Identification of a testis-expressed creatine transporter gene at 16p11.2 and confirmation of the X-linked locus to Xq28. Genomics. 1996 May 15; 34(1):143-6. PMID: 8661037.
      View in: PubMed
    85. Hobson GM, Krahe R, Garcia E, Siciliano MJ, Funanage VL. Regional chromosomal assignments for four members of the MADS domain transcription enhancer factor 2 (MEF2) gene family to human chromosomes 15q26, 19p12, 5q14, and 1q12-q23. Genomics. 1995 Oct 10; 29(3):704-11. PMID: 8575763.
      View in: PubMed
    86. Boucher CA, King SK, Carey N, Krahe R, Winchester CL, Rahman S, Creavin T, Meghji P, Bailey ME, Chartier FL, et al. A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat. Hum Mol Genet. 1995 Oct; 4(10):1919-25. PMID: 8595416.
      View in: PubMed
    87. Krahe R, Ashizawa T, Abbruzzese C, Roeder E, Carango P, Giacanelli M, Funanage VL, Siciliano MJ. Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics. 1995 Jul 01; 28(1):1-14. PMID: 7590731.
      View in: PubMed
    88. Krahe R, Eckhart M, Ogunniyi AO, Osuntokun BO, Siciliano MJ, Ashizawa T. De novo myotonic dystrophy mutation in a Nigerian kindred. Am J Hum Genet. 1995 May; 56(5):1067-74. PMID: 7726160.
      View in: PubMed
    89. Bachinski LL, Krahe R, White BF, Wieringa B, Shaw D, Korneluk R, Thompson LH, Johnson K, Siciliano MJ. An informative panel of somatic cell hybrids for physical mapping on human chromosome 19q. Am J Hum Genet. 1993 Feb; 52(2):375-87. PMID: 8430698.
      View in: PubMed
    90. Physical mapping and functional annotation of 60, 000 human genes. Nature Genetics. 27:98.
    91. Cancer visibility among iranian familial networks. PLoS One. 10.
    92. Myotonic dystrophy type 2. 131-150.
    93. Effects of MDM2, MDM4and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations. PLoS One. 5.
    94. Singular value decomposition-based alternative splicing detection. Journal of the American Statistical Association. 104:944-953.
    95. Mesenchymal deletion of histone demethylase NO66 in mice promotes bone formation. Journal of Bone and Mineral Research. 30:1608-1617.
    KRAHE's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description